Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987
|
|
- Geoffrey Wood
- 6 years ago
- Views:
Transcription
1 Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of Genomics : 1987 Editorial A New Discipline, A New Name, A New Journal Genomics (1987) For the newly developing discipline of [genome] mapping/sequencing (including the analysis of the information), we have adopted the term GENOMICS. The new discipline is born from a marriage of molecular and cell biology with classical genetics and is fostered by computational science. Eric D. Green, MD, PhD 1
2 Human Genome Project: Myriad Applications of Genomics Health, Disease, & Medicine Genomic Medicine An emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., diagnostic or therapeutic decision making) and the other implications of that clinical use. Eric D. Green, MD, PhD 2
3 The Path to Genomic Medicine Human Genome Project Realization of Genomic Medicine Nature International weekly journal of science (2003) A vision for the future of genomics research (2011) Charting a course for genomic medicine from base pairs to bedside Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Eric D. Green, MD, PhD 3
4 ~3,000 bp (0.0001%) of Human Genome Sequence ENCODE: Giving GPS Views of Genomes Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Eric D. Green, MD, PhD 4
5 A vision for the future of genomics research: A blueprint for the genomic era (2003) Nature technological leaps that seem so far off as to be almost fictional but which, if they could be achieved, would revolutionize biomedical research and clinical practice. [For example,] the ability to sequence DNA at costs that are lower by four to five orders of magnitude than the current cost, allowing a human genome to be sequenced for $1000 or less. The $1,000 genome (2014) Nature With a unique programme, the US government has managed to drive the cost of genome sequencing down towards a much anticipated target. Erika Check Hayden (2014) Nature Sequencing a Human Genome Human Genome Project (1 st Sequence) ~1B ~6 8 years Today ~$2 4K ~1 3 days Eric D. Green, MD, PhD 5
6 Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Human Genetic Variation Your Genome: By the Numbers ~6B nucleotides ~3 5M single nucleotide variants ~150K not in databases ~60 not in either parent ~ disruptive variants in genes ~20 completely inactivated genes (both copies) Eric D. Green, MD, PhD 6
7 Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Elucidating the Genomic Bases of Disease Genomic Architecture of Genetic Diseases Manolio et al., J Clin Invest (2008) Rare, Simple, Monogenic, Mendelian Common, Complex, Multigenic, Non Mendelian Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Elucidating the Genomic Bases of Disease Implementing Genomic Medicine Eric D. Green, MD, PhD 7
8 Hot Areas in Genomic Medicine Cancer Genomics Cancer is a Disease of the Genome It takes several mutations to make a cell malignant Routine Clinical Diagnostic Tools Radiographic Imaging Cancer Genome Sequencing Eric D. Green, MD, PhD 8
9 Genomics and Cancer: Here and Now Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Pharmacogenomics Drug toxic but beneficial Drug toxic but NOT beneficial Drug NOT toxic and NOT beneficial Drug Not toxic and beneficial Eric D. Green, MD, PhD 9
10 Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics When Disease Strikes from Nowhere (2014) Nature Children born with disorders not readily explained by standard tests can sometimes be diagnosed through genome sequencing and analysis. NIH Undiagnosed Diseases Network: Seven clinical sites and a coordinating center Stanford Medicine UCLA Baylor College of Medicine National Institutes of Health Vanderbilt University Medical Center Harvard Teaching Hospitals Harvard Medical School Duke University Eric D. Green, MD, PhD 10
11 Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Clinical Sequencing Exploratory Research (CSER) Implementing Genomics into Clinical Practice Network (IGNITE) Eric D. Green, MD, PhD 11
12 Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Prenatal & Newborn Genomic Analysis Noninvasive Prenatal Genome Sequencing Newborn Sequencing in Genomic medicine and public Health (INSIGHT) Eric D. Green, MD, PhD 12
13 Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Prenatal & Newborn Genomic Analysis Clinical Genomics Information Systems Generating a Human Genome Sequence is (Almost) Trivial Clinical Genomics Information Systems Clinical Genome Resource (ClinGen) ClinGen: Sharing Data. Bluilding Knowledge. Improving Care. Eric D. Green, MD, PhD 13
14 The Relevance of Genomics Biomedical Researchers Healthcare Professionals Patients (and Friends & Relatives of Patients) Pervasive DNA & Genomic Imagery Genomics and Society Eric D. Green, MD, PhD 14
15 Genetic Genomic Competency Center (G2C2) Access resources to learn more about use of genomic information in your practice Education repository of resources for diverse healthcare professionals Global Genetics & Genomics Community (G3C) Role of Both the Genomics and other Factors in Human Disease Genome Analysis Technologies mhealth and Environmental Monitoring Technologies Eric D. Green, MD, PhD 15
16 Precision Medicine A broader context for individualizing medical care to advance human health Today: most medical care based on expected response of the average patient Tomorrow: medical care based on individual genomic, environmental, and lifestyle differences that enable more precise ways to prevent and treat disease Precision Medicine Concept is not entirely new: Prescription eyeglasses Blood transfusions What is needed now: Rigorous research program Multidisciplinary approach Audacious scale and scope President Barack Obama Jan 30, 2015 the budget I send this Congress on Monday will include a new Precision Medicine Initiative that brings America closer to curing diseases like cancer and diabetes, and gives all of us access, potentially, to the personalized information that we need to keep ourselves and our families healthier. Eric D. Green, MD, PhD 16
17 Precision Medicine Initiative: The Vision NEAR TERM: Cancer as a Model of Precision Medicine Cancer as leading edge of precision medicine, yet more to learn. Ramp up current efforts to include more cancer types LONGER TERM: Expanding the Model to Other Diseases Create national research cohort of >1 million volunteers. Generate knowledge base for precision medicine. POLICY CHANGES: Remove Barriers to Clinical Implementation Update federal rules protecting research participants. Advance FDA oversight of precision medicine products. Precision Medicine Initiative: Proposed Fiscal Year 2016 Funding National$200 Million FDA $10 Million Office of the National Coordinator for Health Information Technology $5 Million TOTAL $215 Million National Research Cohort >1 million U.S. volunteers Participants to share genomic data, lifestyle information, biological samples all linked to their EHRs Forge new model for doing science that emphasizes: Engaged participants Open, responsible data sharing Strong privacy protections Convert healthcare system into a learning system Eric D. Green, MD, PhD 17
18 Precision Medicine Initiative: Next Steps Working Group of Advisory Committee to the Director Additional meetings/workshops Implementation Trans NIH implementation model Fall 2015: Initial funding opportunities announced Fiscal Year 2016: Funding begins Emphasis on Transparency Planning a National Research Cohort Eric D. Green, MD, PhD 18
Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association
Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Before the House Energy and Commerce Subcommittee on Health 21st Century Cures: Examining the Regulation of Laboratory
More informationTHE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION
THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices
More informationIntegrating Genomics in Family Medicine
Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Integrating Genomics in Family Medicine Brian Stello MD Lehigh Valley Health Network, Brian.Stello@lvhn.org Follow this and
More informationComments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants
Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December
More informationAGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1
AGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1 - Genetics: Progress from Mendel to DNA: Gregor Mendel, in the mid 19 th century provided the
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationPHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14
PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 Submitted resources from physician organization representatives were mapped
More informationThis Webcast Will Begin Shortly
This Webcast Will Begin Shortly If you have any technical problems with the Webcast or the streaming audio, please contact us via email at: webcast@acc.com Thank You! Personalized Medicine Promise and
More informationUNDERSTANDING GENETIC RESEARCH AND ALTERNATING HEMIPLEGIA OF CHILDHOOD. IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process
IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process Genetic discovery AHC Patients Need Help! Researchers collect data on AHC patients (observation) Researchers interpret and evaluate data AHC
More informationThe Future of HealthCare Information Technology
HST.921 / HST.922 Information Technology in the Health Care System of the Future, Spring 2009 Harvard-MIT Division of Health Sciences and Technology Course Directors: Dr. Steven Locke, Dr. Bryan Bergeron,
More informationBridging the Genomics-Health IT Gap for Precision Medicine
Domain Monitor: Analytics Bridging the Genomics-Health IT Gap for Precision Medicine By Jody Ranck The Reality of Precision Medicine Since the White House launched its Precision Medicine initiative in
More informationLearning Objectives. Introduction
Tools for Teaching Genetics in Primary Care Charles J. Macri, MD Leon Moore, Ph.D. NEGEA Baltimore, Maryland 3 March 2001 Learning Objectives Why is genetics an important topic for discussion now? Identify
More informationThe University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Catalog Addendum
The University of Texas MD Anderson Cancer Center UTHealth 2016-2018 Catalog Addendum GSBS 2016-18 Catalog Addendum Table of Contents School Name Change... 1 Areas of Research Concentration Changes...
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationGenomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC
Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results
More informationGenetics and Gene Therapy
Genetics and Gene Therapy Optional Homework Instructions: Print and read this article. Answer the questions at the end to the best of your ability. Extra credit will be given based on quality of responses.
More informationGenomic Medicine in France
Genomic Medicine in France Catherine Nguyen, PhD Director ITMO GGB Genetic, Genomic & Bioinformatic Advancing Disease Modeling in Animal-Based research in Support of Precision Medecine: a Workshop ILAR
More informationE2ES to Accelerate Next-Generation Genome Analysis in Clinical Research
www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution
More informationGenomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)
Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome
More informationPresented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego
Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you
More informationCOPE. FAQs CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES
COPE CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES FAQs This brochure addresses FAQ and is prepared solely for the German market. Local adjustments may be necessary. Please contact us if you require additional
More informationControversy In Pharmacogenomics
Controversy In Pharmacogenomics Alejandra M. De Jesús-Soto, Mark R. Ruprecht, Patricia Vera-González Principal Investigator: Rafael Irizarry, PhD Graduate Assistant: William Townes, MS Harvard T.H. Chan
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce
More information2017 Precision Medicine Study
2017 Precision Medicine Study www.himssanalytics.com Enabling better health through information technology. Precision Medicine Study Introduction DNA genetic testing companies such as Ancestry.com and
More informationBig Data Era in Medicine
Big Data Era in Medicine brought by Genome Omics Information Hiroshi Tanaka Tohoku Medical Megabank Organization Tohoku University and Dept. Biomedical Informatics Tokyo Medical and Dental University the
More informationCHARTING THE COURSE FOR PRECISION MEDICINE
A Friends of Cancer Research White Paper CHARTING THE COURSE FOR PRECISION MEDICINE ADOPTING CONSENSUS ANALYTICAL STANDARDS AND STREAMLINING APPROVAL PATHWAYS FOR POST-MARKET MODIFICATIONS FOR NGS TESTS
More informationRegulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC
Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,
More informationPersonal Genomic Information Management and Personalized Medicine: Challenges, Current Solutions, and Roles of HIM Professionals
Personal Genomic Information Management and Personalized Medicine: Challenges, Current Solutions, and Roles of HIM Professionals Personal Genomic Information Management and Personalized Medicine: Challenges,
More informationSSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview
SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy
More informationPresentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development
Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International
More informationGENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS
More informationTranslational Medicine From Discovery to Health
Translational Medicine From Discovery to Health Jamal A. Ibdah, MD, PhD Sr. Associate Dean & Director, MU Institute for Clinical and Translational Science Translational Medicine Translational Medicine
More informationTargeted Sequencing in the NBS Laboratory
Targeted Sequencing in the NBS Laboratory Christopher Greene, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Gene Sequencing in Public Health Newborn Screening February
More informationTHE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org
THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA themmrf.org ABOUT THE MULTIPLE MYELOMA RESEARCH FOUNDATION The Multiple Myeloma Research Foundation (MMRF) was established in 1998 by identical twin sisters
More informationRare diseases in the 7th EU Framework Programme for Research and Technological Development
Rare diseases in the 7th EU Framework Programme for Research and Technological Development Manuel Hallen, MD Head of Unit Medical & Public Health Research DG Research European Commission 1 The role of
More informationGreenwood Genetic Center
Greenwood Genetic Center: The Center for Human Genetics and The Partnership Campus A Growing Collaborative South Carolina Community Development Association Steve Skinner, M.D. Greenwood Genetic Center
More informationReimbursement Strategy for Companion Diagnostics:
Reimbursement Strategy for Companion Diagnostics: Emerging Models and Requirements Edward E. Berger, Ph.D. Larchmont Strategic Advisors Definition Companion diagnostic A diagnostic test used to predict
More informationCorporate Overview. March 2017
Corporate Overview March 2017 Bionano Genomics Overview Commercial-stage company developing and selling instruments & consumables for whole genome analysis Addressing the needs for: A better understanding
More informationFirst Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing
First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing Amy L. McGuire, JD, PhD Center for Medical Ethics and Health Policy Baylor College of Medicine DTC Advertising Personal Genome
More informationTRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS
TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS THE DOORS ARE OPEN: FEEL FREE TO COME IN CENTOGENE UNLOCKS THE POWER OF GENETIC INSIGHTS TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH GENETIC
More informationTypes of Databases - By Scope
Biological Databases Bioinformatics Workshop 2009 Chi-Cheng Lin, Ph.D. Department of Computer Science Winona State University clin@winona.edu Biological Databases Data Domains - By Scope - By Level of
More informationWe've all heard the dismal statistics: 10,000 known diseases with only 500 treatments. Not great odds if you're a patient.
No longer just passengers, patients are now co-pilots helping to navigate the future of medical progress. But until recently, the pace of progress has been slow. In some diseases, we still utter the words
More information+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA
At the Center for Infectious Disease Research, we use systems biology approaches and cutting-edge technologies to accelerate the development of life-saving drugs, diagnostics and treatments for the world
More informationGenomic Data Is Going Google. Ask Bigger Biological Questions
Genomic Data Is Going Google Ask Bigger Biological Questions You know your research could have a significant scientific impact and answer questions that may redefine how a disease is diagnosed or treated.
More informationRoundtable on Genomics and Precision Health Annual Report
Roundtable on Genomics and Precision Health 2016 Annual Report Message from the Co-Chairs Geoffrey S. Ginsburg and Sharon F. Terry This past year we intentionally reflected on our efforts to date and brought
More informationPersonal Genomics Platform White Paper Last Updated November 15, Executive Summary
Executive Summary Helix is a personal genomics platform company with a simple but powerful mission: to empower every person to improve their life through DNA. Our platform includes saliva sample collection,
More informationGUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS
GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited
More informationISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1
Epidemiologic Research 1 December 12, 2006 Comments on 2006 CIOMS draft Special Ethical Considerations for Epidemiologic Research as proposed supplement to the updated 2002 CIOMS International Ethical
More informationAge-Adjusted Death Rates for Coronary Heart Disease, U.S.,
Age-Adjusted Death Rates for Coronary Heart Disease, U.S., 1950-2004 Deaths/100,000 Population 600 500 400 300 200 100 Risk Factors U.S. Actual U.S. "Could Be" (Based on Japan Actual) 0 1950 1960 1970
More informationShivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare
Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare The world of healthcare is changing - with two revolutionary technologies, genomics and blockchain poised to significantly
More informationOverview of Health Informatics. ITI BMI-Dept
Overview of Health Informatics ITI BMI-Dept Fellowship Week 5 Overview of Health Informatics ITI, BMI-Dept Day 10 7/5/2010 2 Agenda 1-Bioinformatics Definitions 2-System Biology 3-Bioinformatics vs Computational
More informationTarget Enrichment Strategies for Next Generation Sequencing
Target Enrichment Strategies for Next Generation Sequencing Anuj Gupta, PhD Agilent Technologies, New Delhi Genotypic Conference, Sept 2014 NGS Timeline Information burst Nearly 30,000 human genomes sequenced
More informationNordic Register and Biobank Data
Nordic Register and Biobank Data A basis for innovative research on health and welfare Juni Palmgren Karolinska Institutet, Stockholm Nordic conference on Real World Data Helsinki November 2016 Nordic
More informationBiomedical Big Data and Precision Medicine
Biomedical Big Data and Precision Medicine Jie Yang Department of Mathematics, Statistics, and Computer Science University of Illinois at Chicago October 8, 2015 1 Explosion of Biomedical Data 2 Types
More informationRare Diseases: Challenges and Opportunities NIH Perspective
Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes
More informationPLTW Biomedical Science Medical Interventions Course Outline
Follow the fictitious Smith family as you learn about the prevention, diagnosis, and treatment of disease. Play the role of biomedical professionals to analyze case information and diagnose and treat your
More informationMAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE
MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC
More informationarticle May 2008 Vol. 10 No. 5 BACKGROUND AND HISTORY DEFINITION OF LABORATORIES
article May 2008 Vol. 10 No. 5 Molecular genetic testing for ultra rare diseases: models for translation from the research laboratory to the CLIA-certified diagnostic laboratory S. Das, PhD 1, Sherri J.
More informationIntroduction to Pharmacogenetics Competency
Introduction to Pharmacogenetics Competency Updated on 6/2015 Pre-test Question # 1 Pharmacogenetics is the study of how genetic variations affect drug response a) True b) False Pre-test Question # 2 Pharmacogenetic
More informationHuman Genome. The Saudi. Program. An oasis in the desert of Arab medicine is providing clues to genetic disease. By the Saudi Genome Project Team
By the Saudi Genome Project Team The Saudi image licensed by ingram publishing Human Genome Program An oasis in the desert of Arab medicine is providing clues to genetic disease. Digital Object Identifier
More informationPERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS
PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS CLEAR DIAGNOSIS TARGETED TREATMENT STRENGTHENED RESEARCH SUMMARY NATIONAL STRATEGY FOR PERSONALISED MEDICINE 2017-2020 FOREWORD Personalised Medicine
More informationThe Intersection of Genomics Research and the IDE Regulation
The Intersection of Genomics Research and the IDE Regulation Katherine Donigan, Ph.D. Personalized Medicine Staff FDA/CDRH/OIR October 19, 2017 1 In Vitro Diagnostic (IVD) Regulation Through the 1976 medical
More informationUsing Genome Sequencing in the Clinic will Change How You Practice Medicine, Educate and Conduct Research
Using Genome Sequencing in the Clinic will Change How You Practice Medicine, Educate and Conduct Research Howard J. Jacob, Ph.D. Executive Vice President Genomic Medicine Chief Genomic Medicine Officer
More informationGenetic Variation and Genome- Wide Association Studies. Keyan Salari, MD/PhD Candidate Department of Genetics
Genetic Variation and Genome- Wide Association Studies Keyan Salari, MD/PhD Candidate Department of Genetics How many of you did the readings before class? A. Yes, of course! B. Started, but didn t get
More informationLA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES
LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES Francesca Pasinelli Direttore Generale 3 Congresso Nazionale SIFaCT Roma, 9 ottobre 2015 About Telethon Fondazione Telethon is
More informationSummary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015
Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the
More informationThe Future of Clinical and Pharmaceutical Research
The Future of Clinical and Pharmaceutical Research Petra Streng, Industry Business Unit Life Sciences, SAP AG Dr. René Fitterer, Public Services & Healthcare, SAP (Switzerland) Inc. SAP Forum Basel, 20
More informationChristopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013
Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013 Basic Laboratory Research Clinical Research Improved Public Health Translational Research Population Research Basic
More informationIntroduction to Next Generation Sequencing (NGS) Andrew Parrish Exeter, 2 nd November 2017
Introduction to Next Generation Sequencing (NGS) Andrew Parrish Exeter, 2 nd November 2017 Topics to cover today What is Next Generation Sequencing (NGS)? Why do we need NGS? Common approaches to NGS NGS
More informationGENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications May 2008 Volume: TMRGEN08-0515 GENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS 1. Introduction
More informationSecond Quarter 2016 Financial Results. August 4, 2016
Second Quarter 2016 Financial Results August 4, 2016 Cautionary Note Regarding Forward-Looking Statements This presentation and various remarks we make during this presentation contain forward-looking
More informationUpdate on Current FDA Policies and Priorities
Update on Current FDA Policies and Priorities Vernessa Pollard MassMEDIC FDA Update December 12, 2017 Boston Brussels Chicago Dallas Düsseldorf Frankfurt Houston London Los Angeles Miami Milan Munich New
More informationPharmacogenomics in Pain Management
WHITE PAPER Pharmacogenomics in Pain Management Personalized Pain Therapy Authors: ANDREW PURCHASE, BSc Associate Director, Safety & Risk Management PRA Health Sciences LYNN WEBSTER, MD Vice President,
More informationPost-doctoral PharmD Fellowship Programs
Post-doctoral PharmD Fellowship Programs Table of Contents About Bioverativ Messages from Medical & Regulatory Our Pipeline Partnership with Northeastern University Global Medical Fellowship Global Regulatory
More informationLessons from the Human Genome Project that may be applicable to the Exposome Endeavor
Lessons from the Human Genome Project that may be applicable to the Exposome Endeavor Christopher P. Austin. M.D. Director, NIH Chemical Genomics Center Senior Advisor to the NHGRI Director for Translational
More informationDepartment of Pathology fonds
Department of Pathology fonds Compiled by Hemalatha Ramasamy (2005) Revised by Erwin Wodarczak (2008, 2009) Last revised November 2010 *** Institutional records -- researcher access subject to review ***
More informationThe 100,000 Genomes Project Genomics Collaboration Event Finnish Residence
The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary
More informationCS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016
CS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016 Topics Genetic variation Population structure Linkage disequilibrium Natural disease variants Genome Wide Association Studies Gene
More informationMolecular Pathology: The Molecular Basis of Human Disease William B. Coleman, Gregory J. Tsongalis
Molecular Pathology: The Molecular Basis of Human Disease William B. Coleman, Gregory J. Tsongalis 0080922198, 9780080922195 2009 Molecular Pathology: The Molecular Basis of Human Disease 664 pages Academic
More informationA pathogenic mutation was identified in the LDLR gene.
Hereditary High Cholesterol Test ORDERING PHYSICIAN Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA SPECIMEN Type: Saliva Barcode: 333 234234 2343 Collected: Jul 15, 2017 Received: Jul 17,
More informationEnabling Precision Medicine: The Role of Genetics in Clinical Drug Development A Workshop
A Collaboration between the Forum on Drug Discovery, Development, and Translation and the Roundtable on Genomics and Precision Health Enabling Precision Medicine: The Role of Genetics in Clinical Drug
More informationThe IBM Reference Architecture for Healthcare and Life Sciences
The IBM Reference Architecture for Healthcare and Life Sciences Janis Landry-Lane IBM Systems Group World Wide Program Director janisll@us.ibm.com Doing It Right SYMPOSIUM March 23-24, 2017 Big Data Symposium
More informationMEANINGFUL USE CRITERIA PHYSICIANS
MEANINGFUL USE CRITERIA PHYSICIANS The first list is of the 25 Stage 1 Meaningful Use criteria for eligible providers (EP) and comes from the proposed rule: "Medicare and Medicaid Programs; Electronic
More informationHRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies
Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates
More informationThe Integrated Biomedical Sciences Graduate Program
The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to
More informationGuidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff
Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not
More informationBIOCRATES Life Sciences AG Short Company Presentation
BIOCRATES Life Sciences AG Short Company Presentation Dr. Alexandra C. Gruber MBA MMFin Director Business Development / Marketing Austria Showcase Life Science Japan, Tokyo, December 2010 BIOCRATES Life
More informationBuilding on the NHLBI Legacy of Hypertension Research:
Building on the NHLBI Legacy of Hypertension Research: Charting Our Future Together Gary H. Gibbons, M.D. Director National Heart, Lung, and Blood Institute AHA Council on Hypertension September 16, 2015
More informationVisions on the role of Statisticians in the Pharmaceutical Industry. Merete Jørgensen President EFSPI VP Biostatistics, Novo Nordisk A/S
Visions on the role of Statisticians in the Pharmaceutical Industry Merete Jørgensen President EFSPI VP Biostatistics, Novo Nordisk A/S Overview of presentation Vision & Mission A Historical view New Statistical
More informationInsights into the Rare Disease Drug Approval Landscape: Trends and Current Development
Insights into the Rare Disease Drug Approval Landscape: Trends and Current Development Mike Lanthier Operations Research Analyst FDA Office of the Commissioner NORD Rare Diseases & Orphan Products Breakthrough
More informationLecture #1. Introduction to microarray technology
Lecture #1 Introduction to microarray technology Outline General purpose Microarray assay concept Basic microarray experimental process cdna/two channel arrays Oligonucleotide arrays Exon arrays Comparing
More informationUsing local RWD to drive global therapeutic advancements.
Using local RWD to drive global therapeutic advancements. Helsinki, 30 th Nov 2016 Mike Spencer, Head of Real World Evidence, EMEA, Janssen The following represent my own views and not necessarily those
More informationBachelor of Science (Hons) / Bachelor of Science Biomedical Science
Bachelor of Science (Hons) / Bachelor of Science Biomedical Science Awarded by In collaboration with This degree course is designed to give you a broad understanding of the scientific investigation of
More informationNanotechnology and Advanced Materials for more effective Healthcare
Nanotechnology and Advanced Materials for more effective Healthcare This challenge taps into the potential of nanotechnologies and advanced materials to enable more effective therapies and diagnostics
More information